APA

Doyle K., Lönn H., Käck H., Van de Poël A., Swallow S., Gardiner P., Connolly S., Root J., Wikell C., Dahl G., Stenvall K. & Johannesson P. (20170606). Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). : Journal of medicinal chemistry.

Chicago

Doyle Kevin, Lönn Hans, Käck Helena, Van de Poël Amanda, Swallow Steve, Gardiner Philip, Connolly Stephen, Root James, Wikell Cecilia, Dahl Göran, Stenvall Kristina and Johannesson Petra. 20170606. Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). : Journal of medicinal chemistry.

Harvard

Doyle K., Lönn H., Käck H., Van de Poël A., Swallow S., Gardiner P., Connolly S., Root J., Wikell C., Dahl G., Stenvall K. and Johannesson P. (20170606). Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). : Journal of medicinal chemistry.

MLA

Doyle Kevin, Lönn Hans, Käck Helena, Van de Poël Amanda, Swallow Steve, Gardiner Philip, Connolly Stephen, Root James, Wikell Cecilia, Dahl Göran, Stenvall Kristina and Johannesson Petra. Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). : Journal of medicinal chemistry. 20170606.